Complete Filing Data
SeaStar Medical Holding Corp reported Stockholders Equity of $10.42 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean SeaStar Medical Holding Corp did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Income * | -$12.2M | -$24.8M | -$26.2M | -$12.2M | -$4.6M |
| Operating Income Loss | -$12.2M | -$17.8M | -$14.2M | -$11.6M | -$4.4M |
| General And Administrative Expense | $5.8M | $8.9M | $8.2M | $6.9M | $1.7M |
| Research And Development Expense | $7.5M | $9.1M | $6.0M | $2.5M | $2.8M |
| Operating Expenses | $13.4M | $18.0M | $14.2M | $11.6M | $4.4M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$12.1M | -$24.8M | -$26.2M | -$12.2M | -$4.6M |
| Income Tax Expense Benefit | $3.0K | $3.0K | $0.00 | $1.0K | -$1.0K |
| Other Nonoperating Income Expense | -$7.0M | -$12.0M | -$580.0K | -$148.0K | |
| Interest Expense | $244.0K | $1.1M | $630.0K | $212.0K | |
| Income Taxes Paid | $3.0K | $3.0K | $0.00 | $1.0K | $0.00 |
| Revenue From Contract With Customer Excluding Assessed Tax | $1.2M | $135.0K | $0.00 | ||
| Cost Of Goods And Services Sold | $53.0K | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$3.5M | -$2.0M | -$3.8M | -$4.5M | -$3.2M | -$12.7M | -$7.2M | -$2.4M | -$7.1M | -$1.9M | -$902.0K | -$1.0M | $236.0K | -$2.0M | $1.7M | -$5.2K |
| Operating Income Loss | -$3.6M | -$1.8M | -$3.8M | -$4.5M | -$4.7M | -$4.0M | -$2.9M | -$3.8M | -$4.6M | -$1.8M | -$1.3M | -$812.0K | -$411.4K | -$209.7K | -$126.0K | -$5.2K |
| General And Administrative Expense | $1.9M | $1.0M | $1.7M | $2.2M | $2.3M | $2.3M | $1.9M | $1.8M | $2.9M | $1.0M | $716.0K | $457.0K | $411.4K | $209.7K | $126.0K | $5.2K |
| Research And Development Expense | $1.9M | $1.0M | $2.4M | $2.3M | $2.3M | $1.7M | $1.1M | $2.0M | $1.7M | $727.0K | $596.0K | $355.0K | ||||
| Operating Expenses | $3.7M | $2.1M | $4.1M | $4.5M | $4.7M | $4.0M | $2.9M | $3.8M | $4.6M | $1.8M | $1.3M | $812.0K | ||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$3.5M | -$2.0M | -$3.8M | -$4.5M | -$3.2M | -$12.7M | -$7.2M | -$2.4M | -$7.1M | -$1.9M | -$902.0K | -$1.0M | ||||
| Income Tax Expense Benefit | $0.00 | $0.00 | $3.0K | $0.00 | $3.0K | $0.00 | $0.00 | $5.0K | $0.00 | $1.0K | $0.00 | $0.00 | ||||
| Other Nonoperating Income Expense | -$246.0K | $53.0K | -$22.0K | $1.4M | -$8.7M | -$4.3M | $1.3M | -$2.5M | -$122.0K | $410.0K | -$192.0K | |||||
| Interest Expense | $9.0K | $11.0K | $272.0K | $82.0K | $143.0K | $224.0K | $225.0K | $433.0K | $123.0K | $191.0K | $169.0K | |||||
| Income Taxes Paid | ||||||||||||||||
| Revenue From Contract With Customer Excluding Assessed Tax | $183.0K | $338.0K | $293.0K | $68.0K | $0.00 | $0.00 | $0.00 | |||||||||
| Cost Of Goods And Services Sold | $14.0K | $27.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Stockholders Equity | $10.4M | -$2.2M | -$13.9M | -$20.8M | -$2.8M | $1.8M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $47.0K | $510.0K | $2.8M | |||
| Retained Earnings Accumulated Deficit | -$151.7M | -$139.6M | -$114.7M | -$88.5M | -$76.3M | -$5.2K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $1.6M | $129.0K | -$463.0K | -$2.3M | ||
| Liabilities Current | $3.7M | $6.8M | $13.0M | $16.1M | $3.1M | $249.4K |
| Liabilities And Stockholders Equity | $14.2M | $4.7M | $3.5M | $3.0M | $603.0K | $269.2K |
| Liabilities | $3.7M | $6.8M | $17.4M | $23.8M | $3.4M | $249.4K |
| Cash | $51.6K | $38.4K | ||||
| Assets | $14.2M | $4.7M | $3.5M | $3.0M | $603.0K | $269.2K |
| Assets Current | $13.6M | $3.8M | $2.3M | $1.5M | $601.0K | |
| Accrued Liabilities Current | $2.3M | $3.2M | $1.5M | $2.2M | $186.0K | |
| Accounts Payable Current | $948.0K | $3.0M | $4.4M | $1.9M | $85.0K | |
| Other Assets | $1.2M | $1.5M | $2.0K | |||
| Notes Payable Current | $525.0K | $574.0K | $565.0K | $1.2M | $0.00 | |
| Common Stock Value | $4.0K | $2.0K | $1.0K | $1.0K | ||
| Repayments Of Convertible Debt | $0.00 | $700.0K | $400.0K | $0.00 | ||
| Long Term Notes Payable | $0.00 | $4.1M | $7.7M | $0.00 | ||
| Amortization Of Debt Discount Premium | $0.00 | $242.0K | $140.0K | |||
| Amortization Of Deferred Financing Costs | $102.0K | $48.0K | $0.00 | |||
| Payment Of Notes Payable | $5.4M | $4.9M | $15.0K | |||
| Other Receivables Net Current | $0.00 | $12.0K | $58.0K | |||
| Non Cash Accrued Interest Added To Principal Of Convertible Notes | $0.00 | -$341.0K | -$72.0K | |||
| Repayments Of Notes Payable | $834.0K | $5.4M | $0.00 | $63.0K | $0.00 | |
| Derivative Liabilities Current | $1.0K | $33.0K | $0.00 | $471.0K | ||
| Notes Payable Related Parties Classified Current | $0.00 | $2.4M | $126.4K | |||
| Gains Losses On Extinguishment Of Debt | $0.00 | -$4.9M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $11.5M | $3.3M | $565.0K | -$2.1K | -$6.9M | -$4.5M | -$16.0M | -$11.8M | -$23.4M | -$5.9M | -$4.4M | -$3.8M | -$10.7M | -$10.9M | -$8.9M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $6.3M | $5.3M | $1.8M | $2.1M | $1.2M | $5.0M | $176.0K | $73.0K | $13.0K | $725.0K | $49.0K | $613.0K | $207.0K | $165.8K | $339.7K | $503.3K | ||
| Retained Earnings Accumulated Deficit | -$148.8M | -$145.3M | -$143.3M | -$135.1M | -$130.7M | -$127.4M | -$8.9M | -$7.0M | -$7.2M | -$10.7M | -$10.9M | -$8.9M | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $3.5M | $4.8M | $678.0K | -$303.0K | $464.9K | $38.4K | ||||||||||||
| Liabilities Current | $4.1M | $5.0M | $7.0M | $6.6M | $9.9M | $9.6M | $9.4M | $7.4M | $7.6M | $277.3K | $192.3K | $290.3K | ||||||
| Liabilities And Stockholders Equity | $15.5M | $8.4M | $7.6M | $4.6M | $3.5M | $7.7M | $107.3M | $106.0M | $106.0M | $106.2M | $106.5M | $106.8M | ||||||
| Liabilities | $4.1M | $5.0M | $7.0M | $6.6M | $10.4M | $12.2M | $9.4M | $7.4M | $7.6M | $11.3M | $11.9M | $10.2M | ||||||
| Cash | $165.8K | $339.7K | $503.3K | |||||||||||||||
| Assets | $15.5M | $8.4M | $7.6M | $4.6M | $3.5M | $7.7M | $107.3M | $106.0M | $106.0M | $106.2M | $106.5M | $106.8M | ||||||
| Assets Current | $14.9M | $7.6M | $6.8M | $3.6M | $2.4M | $6.5M | $107.3M | $106.0M | $106.0M | $624.9K | $951.3K | $1.3M | $269.2K | |||||
| Accrued Liabilities Current | $2.0M | $1.9M | $3.3M | $2.3M | $2.3M | $1.5M | $1.0M | $309.5K | $277.3K | $49.3K | $4.3K | $123.0K | ||||||
| Accounts Payable Current | $2.0M | $3.2M | $3.4M | $3.7M | $4.1M | $3.9M | ||||||||||||
| Other Assets | $736.0K | $813.0K | $892.0K | $970.0K | $1.1M | $1.2M | ||||||||||||
| Notes Payable Current | $0.00 | $0.00 | $363.0K | $0.00 | $3.1M | $357.0K | $0.00 | |||||||||||
| Common Stock Value | $3.0K | $2.0K | $2.0K | $1.0K | $1.0K | $8.0K | ||||||||||||
| Repayments Of Convertible Debt | $0.00 | $10.0K | $0.00 | |||||||||||||||
| Long Term Notes Payable | $0.00 | $0.00 | $2.6M | $0.00 | ||||||||||||||
| Amortization Of Debt Discount Premium | $0.00 | $26.0K | $99.0K | $109.0K | ||||||||||||||
| Amortization Of Deferred Financing Costs | $11.0K | $27.0K | $4.0K | $0.00 | ||||||||||||||
| Payment Of Notes Payable | $2.6M | $0.00 | ||||||||||||||||
| Other Receivables Net Current | ||||||||||||||||||
| Non Cash Accrued Interest Added To Principal Of Convertible Notes | ||||||||||||||||||
| Repayments Of Notes Payable | $222.0K | $1.8M | $2.6M | |||||||||||||||
| Derivative Liabilities Current | $1.0K | |||||||||||||||||
| Notes Payable Related Parties Classified Current | ||||||||||||||||||
| Gains Losses On Extinguishment Of Debt | $0.00 | $5.8M | -$4.9M | $0.00 | $0.00 | $0.00 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Share-Based Compensation * | $624.0K | $887.0K | $1.9M | $1.3M | $14.0K |
| Net Cash Provided By Used In Operating Activities | -$13.6M | -$16.0M | -$10.3M | -$7.8M | -$5.1M |
| Net Cash Provided By Used In Financing Activities | $23.8M | $17.7M | $10.4M | $7.3M | $2.8M |
| Increase Decrease In Prepaid Expense | -$538.0K | -$297.0K | $97.0K | $1.1M | -$12.0K |
| Increase Decrease In Accounts Payable | -$2.1M | -$1.3M | $2.4M | $1.5M | -$297.0K |
| Proceeds From Convertible Debt | $0.00 | $979.0K | $8.0M | $1.7M | $2.7M |
| Proceeds From Notes Payable | $767.0K | $713.0K | $800.0K | $1.9M | $0.00 |
| Proceeds From Issuance Of Common Stock | $16.1M | $17.4M | $4.7M | $0.00 | |
| Increase Decrease In Accrued Liabilities | -$920.0K | $1.9M | $517.0K | $2.1M | |
| Increase Decrease In Inventories | $66.0K | $0.00 | $0.00 | -$55.0K | |
| Proceeds From Sale Of Recycled Shares | 0.00 | 1.9M | 40.0K | 0.00 | |
| Increase Decrease In Other Receivables | $0.00 | -$12.0K | -$4.0K | $0.00 | |
| Increase Decrease In Other Operating Assets | -$314.0K | -$313.0K | $0.00 | ||
| Increase Decrease In Notes Receivables | -$6.1M | -$5.4M | $0.00 | ||
| Proceeds From Warrant Exercises | $1.8M | $853.0K | $592.0K | $0.00 | |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $2.1M | -$450.0K | |||
| Net Cash Provided By Used In Investing Activities | -$105.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|---|---|
| Share-Based Compensation * | $167.0K | $434.0K | $505.0K | $4.0K | ||
| Net Cash Provided By Used In Operating Activities | -$2.7M | -$3.5M | -$2.3M | -$587.0K | -$280.3K | -$113.0K |
| Net Cash Provided By Used In Financing Activities | $6.1M | $8.3M | $3.0M | $284.0K | $106.3M | $151.4K |
| Increase Decrease In Prepaid Expense | -$501.0K | -$614.0K | -$318.0K | $185.0K | -$90.8K | |
| Increase Decrease In Accounts Payable | $351.0K | -$493.0K | $1.1M | $114.0K | ||
| Proceeds From Convertible Debt | $0.00 | $979.0K | $3.0M | $0.00 | ||
| Proceeds From Notes Payable | $0.00 | $100.0K | $284.0K | |||
| Proceeds From Issuance Of Common Stock | $1.6M | $4.5M | $1.1M | $0.00 | $103.5M | |
| Increase Decrease In Accrued Liabilities | $67.0K | $21.0K | $0.00 | $195.0K | -$118.7K | |
| Increase Decrease In Inventories | $44.0K | $0.00 | ||||
| Proceeds From Sale Of Recycled Shares | 0.00 | 1.9M | 0.00 | |||
| Increase Decrease In Other Receivables | $0.00 | -$12.0K | $0.00 | |||
| Increase Decrease In Other Operating Assets | -$79.0K | -$2.0K | $0.00 | |||
| Increase Decrease In Notes Receivables | $0.00 | -$5.8M | -$2.2M | $0.00 | ||
| Proceeds From Warrant Exercises | $2.0K | $853.0K | $0.00 | |||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | ||||||
| Net Cash Provided By Used In Investing Activities | -$105.6M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$6.63 | -$30.26 | -$1.48 | -$0.63 | ||
| Weighted Average Number Of Shares Outstanding Basic | 2.1M | 374.4K | 866.8K | 8.2M | 7.2M | |
| Earnings Per Share Basic | $-5.86 | $-66.33 | $-30.26 | $-1.48 | $-0.63 | |
| Weighted Average Number Of Diluted Shares Outstanding | 3.7M | 866.8K | 8.2M | 7.2M | ||
| Common Stock Shares Authorized | 450.0M | 500.0M | 500.0M | 100.0M | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 1.0M | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 3.8M | 650.6K | 2.0M | 12.7M | ||
| Common Stock Shares Issued | 3.8M | 650.6K | 2.0M | 12.7M | ||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.18 | -$0.44 | -$1.10 | -$1.03 | -$4.73 | -$9.02 | -$4.10 | -$0.54 | -$0.26 | -$0.12 | -$0.14 | -$0.15 | $0.18 | |||
| Weighted Average Number Of Shares Outstanding Basic | 26.4M | 11.3M | 8.6M | 4.1M | 3.2M | 2.7M | 801.9K | 597.3K | 13.0M | 7.2M | 7.2M | 7.2M | 13.0M | 9.7M | ||
| Earnings Per Share Basic | $-0.13 | $-0.18 | $-0.44 | $-1.10 | $-1.03 | $-4.73 | $-9.02 | $-4.10 | $-0.54 | $-0.26 | $-0.12 | $-0.14 | $0.18 | |||
| Weighted Average Number Of Diluted Shares Outstanding | 11.3M | 8.6M | 4.1M | 3.2M | 2.7M | 801.9K | 597.3K | 13.0M | 7.2M | 7.2M | 7.2M | 13.0M | 9.7M | |||
| Common Stock Shares Authorized | 450.0M | 450.0M | 450.0M | 500.0M | 500.0M | 500.0M | 500.0M | 100.0M | 100.0M | |||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Outstanding | 34.1M | 17.3M | 9.3M | 4.2M | 1.9M | 75.4M | 27.2M | 18.1M | 13.3M | |||||||
| Common Stock Shares Issued | 34.1M | 17.3M | 9.3M | 4.2M | 3.2M | 75.4M | 27.2M | 18.1M | 13.3M | |||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Fair Value Adjustment Of Warrants | -$32.0K | $697.0K | -$545.0K | -$10.9M | $27.0K | |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $624.0K | $814.0K | $1.9M | $1.3M | $14.0K | |
| Prepaid Expense Current | $1.3M | $1.8M | $2.1M | $1.5M | $33.0K | |
| Additional Paid In Capital | $162.1M | $137.4M | $100.9M | $67.7M | $73.5M | $24.8K |
| Interest Paid Net | $0.00 | $553.0K | $1.1M | $6.0K | $0.00 | |
| Investment Income Interest | $325.0K | $101.0K | $0.00 | $11.8K | ||
| Other Income | $0.00 | $151.0K | $0.00 | $91.0K | ||
| Change In Fair Value Of Convertible Notes | -$6.1M | -$5.4M | $0.00 | |||
| Issuance Of Convertible Note Warrant | $586.0K | $2.7M | $0.00 | |||
| Change In Fair Value Of Forward Option Prepaid Forward Contracts | $10.2M | $0.00 | ||||
| Stock Issued During Period Value Exercise Of Warrants | $1.8M | $4.0M | $1.7M | |||
| Stock Issued During Period Value Conversion Of Convertible Securities | $10.2M | $10.4M | ||||
| Repayment Of Paycheck Protection Program Loan | $0.00 | $20.0K | ||||
| Gain Loss On Sale Of Recycled Shares | -1.0K | 0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fair Value Adjustment Of Warrants | $0.00 | -$16.0K | -$16.0K | -$192.0K | -$1.9M | $2.8M | -$1.0M | -$723.0K | -$36.0K | $0.00 | $0.00 | -$3.6M | -$644.7K | $1.8M | -$1.8M | |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $290.0K | $97.0K | $167.0K | $200.0K | $41.0K | $434.0K | $440.0K | $555.0K | $505.0K | $357.0K | $345.0K | $4.0K | ||||
| Prepaid Expense Current | $807.0K | $1.1M | $1.3M | $1.5M | $1.2M | $1.5M | $132.9K | $188.9K | $128.1K | $47.1K | $74.0K | $96.1K | $230.8K | |||
| Additional Paid In Capital | $160.3M | $148.7M | $143.9M | $133.1M | $123.8M | $123.0M | $0.00 | $5.3M | $5.3M | |||||||
| Interest Paid Net | $0.00 | $508.0K | $0.00 | |||||||||||||
| Investment Income Interest | $107.0K | $45.0K | $48.0K | $58.0K | $25.0K | $0.00 | $0.00 | $0.00 | $361.7K | $67.6K | $2.6K | $2.7K | $1.8K | |||
| Other Income | $0.00 | $149.0K | $0.00 | $0.00 | $1.0K | |||||||||||
| Change In Fair Value Of Convertible Notes | $0.00 | $0.00 | $0.00 | -$387.0K | -$5.8M | -$291.0K | -$100.0K | $100.0K | $0.00 | $0.00 | ||||||
| Issuance Of Convertible Note Warrant | $0.00 | $586.0K | $500.0K | $0.00 | ||||||||||||
| Change In Fair Value Of Forward Option Prepaid Forward Contracts | $0.00 | $0.00 | $69.0K | $1.7M | $0.00 | $0.00 | $0.00 | |||||||||
| Stock Issued During Period Value Exercise Of Warrants | $1.8M | $2.0K | -$56.0K | $4.0M | ||||||||||||
| Stock Issued During Period Value Conversion Of Convertible Securities | $826.0K | $9.4M | $2.4M | $1.9M | ||||||||||||
| Repayment Of Paycheck Protection Program Loan | ||||||||||||||||
| Gain Loss On Sale Of Recycled Shares | 0.00 | 0.00 | 1.3M | 0.00 | 0.00 | 0.00 |
Most recent annual filing with the SEC: March 25, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.